HOWL vs HYFT

Werewolf Therapeutics, Inc. vs MindWalk Holdings Corp. — Valuation Comparison 2026

HOWL

Pharmaceutical Preparations
Werewolf Therapeutics, Inc.
Quality
4.1
out of 10
Value Trap
30
LOW
Price
$0.45
Last close
Models
7/13
Active
VS

HYFT

Pharmaceutical Preparations
MindWalk Holdings Corp.
Quality
1.7
out of 10
Value Trap
Price
$1.76
Last close
Models
8/13
Active

Model-by-Model Comparison

ModelType HOWL Fair ValueHOWL Upside HYFT Fair ValueHYFT Upside
Bayesian DCF Intrinsic $0.17 -61.5% $0.42 -75.9%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.05 -93.6% $0.35 -80.0%
Dynamic NAV Asset-Based $•••.•• ••.•% $•••.•• ••.•%
PWERM Option-Based $0.83 +85.2% $1.40 -20.7%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for HOWL vs HYFT — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

HOWL vs HYFT — Which Stock Is More Undervalued?

HOWL scores higher with a 4.1/10 quality rating vs HYFT's 1.7/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Werewolf Therapeutics, Inc. (HOWL) and MindWalk Holdings Corp. (HYFT) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

HOWL currently trades at $0.45 with a QOC of 4.1/10, while HYFT trades at $1.76 with a QOC of 1.7/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).